Endocannabinoids such as AEA and CB2 receptors and enzymes such as fatty acid amide hydrolase (FAAH) influence retrograde signalling (observed in Alzheimer’s disease) in the brain. This evidence concerns the gene FAAH and Alzheimer disease.